Analysts Set Teladoc Health, Inc. (NYSE:TDOC) Target Price at $18.22

Teladoc Health, Inc. (NYSE:TDOC) has received a consensus rating of “Hold” from the eighteen brokerages that are currently covering the stock, MarketBeat reports. Twelve analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $18.22.

Several research firms recently issued reports on TDOC. TD Cowen dropped their target price on Teladoc Health from $16.00 to $15.00 and set a “hold” rating on the stock in a report on Friday, April 26th. Stifel Nicolaus dropped their price objective on Teladoc Health from $21.00 to $16.00 and set a “hold” rating on the stock in a research note on Friday, April 26th. Bank of America dropped their price objective on Teladoc Health from $16.50 to $13.50 and set a “neutral” rating on the stock in a research note on Tuesday, May 14th. Cantor Fitzgerald started coverage on Teladoc Health in a research report on Thursday, February 29th. They issued an “overweight” rating and a $22.00 target price on the stock. Finally, Leerink Partnrs reaffirmed a “market perform” rating on shares of Teladoc Health in a research report on Monday, February 26th.

Teladoc Health Stock Up 0.3 %

Shares of Teladoc Health stock opened at $11.48 on Wednesday. The company has a quick ratio of 3.74, a current ratio of 3.82 and a debt-to-equity ratio of 0.67. Teladoc Health has a 12 month low of $11.32 and a 12 month high of $30.41. The business has a fifty day simple moving average of $13.58 and a 200 day simple moving average of $17.00. The stock has a market cap of $1.95 billion, a PE ratio of -8.14 and a beta of 0.97.

Teladoc Health (NYSE:TDOC) last posted its earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.02). Teladoc Health had a negative net margin of 8.90% and a negative return on equity of 10.13%. The business had revenue of $646.13 million during the quarter, compared to analyst estimates of $637.31 million. During the same period in the previous year, the firm posted ($0.37) earnings per share. The firm’s revenue was up 2.7% on a year-over-year basis. Research analysts predict that Teladoc Health will post -1.05 EPS for the current year.

Insider Activity

In other news, EVP Andrew Turitz sold 6,190 shares of the firm’s stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $14.52, for a total value of $89,878.80. Following the completion of the sale, the executive vice president now directly owns 39,429 shares in the company, valued at approximately $572,509.08. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In other Teladoc Health news, EVP Andrew Turitz sold 6,190 shares of Teladoc Health stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $89,878.80. Following the completion of the transaction, the executive vice president now owns 39,429 shares in the company, valued at approximately $572,509.08. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Daniel Trencher sold 6,780 shares of Teladoc Health stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $14.52, for a total value of $98,445.60. Following the transaction, the insider now owns 28,192 shares of the company’s stock, valued at approximately $409,347.84. The disclosure for this sale can be found here. Insiders sold a total of 147,202 shares of company stock worth $2,085,611 in the last three months. Company insiders own 0.95% of the company’s stock.

Institutional Investors Weigh In On Teladoc Health

A number of hedge funds have recently modified their holdings of the stock. ICA Group Wealth Management LLC bought a new stake in Teladoc Health during the 4th quarter valued at $28,000. Hexagon Capital Partners LLC grew its position in shares of Teladoc Health by 204.4% during the 4th quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider’s stock valued at $34,000 after purchasing an additional 1,065 shares in the last quarter. RIA Advisory Group LLC purchased a new position in shares of Teladoc Health during the 4th quarter valued at $36,000. GAMMA Investing LLC purchased a new position in shares of Teladoc Health during the 4th quarter valued at $41,000. Finally, Principal Securities Inc. purchased a new position in shares of Teladoc Health during the 4th quarter valued at $45,000. Institutional investors own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.